It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Actin cytoskeleton is well-known for providing structural/mechanical support, but whether and how it regulates chromatin and cell fate reprogramming is far less clear. Here, we report that MKL1, the key transcriptional co-activator of many actin cytoskeletal genes, regulates genomic accessibility and cell fate reprogramming. The MKL1-actin pathway weakens during somatic cell reprogramming by pluripotency transcription factors. Cells that reprogram efficiently display low endogenous MKL1 and inhibition of actin polymerization promotes mature pluripotency activation. Sustained MKL1 expression at a level seen in typical fibroblasts yields excessive actin cytoskeleton, decreases nuclear volume and reduces global chromatin accessibility, stalling cells on their trajectory toward mature pluripotency. In addition, the MKL1-actin imposed block of pluripotency can be bypassed, at least partially, when the Sun2-containing linker of the nucleoskeleton and cytoskeleton (LINC) complex is inhibited. Thus, we unveil a previously unappreciated aspect of control on chromatin and cell fate reprogramming exerted by the MKL1-actin pathway.
MKL1 is a key transcriptional co-activator of actin cytoskeleton genes. Here the authors show that MKL1 activation in somatic cells reduces chromatin accessibility and hinders full reprogramming to pluripotency. Reduction of MKL1, disruption of actin cytoskeleton and its links to the nucleus relieve this repression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Yale University, Department of Cell Biology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
2 Yale University, Department of Cell Biology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Pathology, Yale Cancer Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
3 Yale University, Department of Pediatrics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
4 Yale University, Department of Medicine (Cardiology), New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
5 Yale University, Department of Cell Biology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
6 Yale University, Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
7 Yale University, Department of Pathology, Yale Cancer Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Pediatrics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
8 Yale University, Department of Cell Biology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Laboratory Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)